Manage episode 290973560 series 2818443
Correspondent Samuel Okocha analyses the present and potential future of Twitter Inc.
From London James Athey at Aberdeen Standard Investments questions whether SPACs can continue at their current level.
From San Diego California Peter Merrick of MerrickWealth.com looks at the winners (Taiwan Semiconductor, Intel) and losers (Ford, General Motors, Toyota and Volkswagen) in the current chip shortage.
Gavin Graham dissects the pharmaceutical stock sector and the impact of vaccine news, looking at Pfizer, Johnson & Johnson, AstraZeneca, Moderna and other pharma companies.